Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Partnering

Partnering
orange

Commitment + Responsibility

IFA Global Conference on Ageing 2018
“Towards a Decade of Healthy Ageing – From Evidence to Action”
green

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

Cancer is 100 diseases and each patient is unique
blue

Commitment + Responsibility

We support the EFPIA campaign
#WeWontRest
green

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Treatment + Care

Why radiology could be key to determining treatment for cardiovascular diseases
blue

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·2 days

#HealthyAging … it starts with mindfulness.

Becoming more aware of your surroundings could help increase your love for your home. When taking a walk, look at the trees, the grass, kids playing. Can you notice anything new? Share your experiences with us in the comments below! bit.ly/HealthyBayer

twitter·21 hours

@TrippBiotage We're glad to hear of your recovery! Due to regulations, we cannot name pharma products/AIs and will…

youtube·1 month

Fish Soup | Easy Healthy Recipes #10

Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-08-14

Bayer and Haplogen collaborate to develop new treatments against pulmonary diseases

2018-08-10

Bayer announces acceptance of nine abstracts on the use of Xarelto® in patients from a broad range of clinical and real-world studies

2018-07-27

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease

2018-07-24

Bayer receives approval for Kovaltry® in China for the treatment of children and adults with Hemophilia A

2018-07-09

XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation
Press center